33，Huang C,Wu M,Xu Q,et al. Overrexpression of the MDR1 gene and p-glycoprotein in humanhepatocellular carcinoma. J Natl Cancer Inst,1992,84:262～265.
44，Thottassery JV,Zambetti GP,Arimori K,et al. p53-dependent regulation of MDR1 geneexpression causes selective resistance to chemotherapeutic agents. Proc Natl AcadSci,1997,94:11037～11042.
55，Bueso-Ramos CE,Yang Y,de Leon E,et al. The human mdm-2 oncogene is overexpressec inleukemias. Blood,1993,82(9):2617～2623.
66，Goldsmith ME,Madden MJ,Morrow CS,et al. A Y-box consensus sequence is required forbasal expression of the human multidrug resistance gene. J Biol Chem,1993,268(8):5856～5860.
77，Ohga T,Uchiumi T,Makino Y，et al. Direct involvement of the Y-box binding preteinYB-1 in genotoxic stress-induced activation of the human multidrug resistance 1 gene. JBiol Chem,1998,273(11);5997～6000.
88，Cheng AL,Chuang SE,Fine RL,et al. Inhibition of the membrane translocation andactivation of protein kinase C,and potentiation of doxorubicin-induced apoptosis ofhepatocellular carcinoma cells by tamoxifen. Biochem Pharmacol，1998,55(4):523～531.
99，Zacherl J,Hamilton G,Thalhammer T,et al. Inhibition of P-glycoprotein-mediatedvinblastine transport across HCT-8 intestinal carcinoma monolayers byverapamil,cyclsporine A and SDZ PSC 833 in dependence on extracellular pH. Cancer ChemoPharm,1994,34(2):125～132.
1010，Takebayashi Y,Akiyama SI,Natsugoe S,et al. The expression of multidrug resistanceprotein in human gastrointestinal tract carcinomas. Cancer,1998,82(4):661～666.
